Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A-M Alguacil

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Thoracic and Cardiovascular Surgeon|April 12, 2011
Pericardial synovial sarcomaF Akerström, B Santos, A-M Alguacil, et al.
Public Health|February 16, 2019
Rapid assessment of enhanced safety surveillance for influenza vaccineA M Alguacil-Ramos, A Portero-Alonso, E Pastor-Villalba, et al.
Public Health|March 16, 2016
Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination systemA M Alguacil-Ramos, J Muelas-Tirado, T M Garrigues-Pelufo, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|September 18, 2012
[Suspected adverse events to measles, mumps and rubella vaccine reported to the Community of Valencia Pharmacovigilance Centre]S Pérez-Vilar, M V Gutiérrez-Gimeno, M A Rodríguez-Galán, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Thoracic and Cardiovascular Surgeon|April 12, 2011
Pericardial synovial sarcomaF Akerström, B Santos, A-M Alguacil, et al.
Public Health|February 16, 2019
Rapid assessment of enhanced safety surveillance for influenza vaccineA M Alguacil-Ramos, A Portero-Alonso, E Pastor-Villalba, et al.
Public Health|March 16, 2016
Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination systemA M Alguacil-Ramos, J Muelas-Tirado, T M Garrigues-Pelufo, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|September 18, 2012
[Suspected adverse events to measles, mumps and rubella vaccine reported to the Community of Valencia Pharmacovigilance Centre]S Pérez-Vilar, M V Gutiérrez-Gimeno, M A Rodríguez-Galán, et al.
Pageof 1